Literature DB >> 23143117

[Ketamine for treatment of therapy-resistant depression: a case study].

F Segmiller, D Frisse, D Eser, H-J Möller, T Rüther, C Schüle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23143117     DOI： 10.1007/s00115-012-3636-0

Source DB:  PubMed          Journal:  Nervenarzt        ISSN： 0028-2804            Impact factor:   1.214


× No keyword cloud information.
  5 in total

1.  A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.

Authors:  Carlos A Zarate; Jaskaran B Singh; Paul J Carlson; Nancy E Brutsche; Rezvan Ameli; David A Luckenbaugh; Dennis S Charney; Husseini K Manji
Journal:  Arch Gen Psychiatry       Date:  2006-08

2.  Antidepressant effects of ketamine in depressed patients.

Authors:  R M Berman; A Cappiello; A Anand; D A Oren; G R Heninger; D S Charney; J H Krystal
Journal:  Biol Psychiatry       Date:  2000-02-15       Impact factor: 13.382

3.  Comparison of racemic ketamine and S-ketamine in treatment-resistant major depression: report of two cases.

Authors:  Robert Paul; Nadine Schaaff; Frank Padberg; Hans-Jürgen Möller; Thomas Frodl
Journal:  World J Biol Psychiatry       Date:  2009       Impact factor: 4.132

4.  Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression.

Authors:  Marije aan het Rot; Katherine A Collins; James W Murrough; Andrew M Perez; David L Reich; Dennis S Charney; Sanjay J Mathew
Journal:  Biol Psychiatry       Date:  2010-01-15       Impact factor: 13.382

5.  Ketamine use, cognition and psychological wellbeing: a comparison of frequent, infrequent and ex-users with polydrug and non-using controls.

Authors:  Celia J A Morgan; Leslie Muetzelfeldt; H Valerie Curran
Journal:  Addiction       Date:  2009-01       Impact factor: 6.526
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.